58278 Federal Register / Vol. 65, No. 189 / Thursday, September 28, 2000 / Notices

among the agency’s diverse customers.

For this reason CDC requests and

welcomes comments from customers

regarding all aspects of ‘‘E-Grants’’

including but not limited to the

following areas:

IT Infrastructure

CDC business customers (grantees and

applicants) would need a computer,

printer, connection to the Internet, web

browser capable of 128-bit encrypted

secure transmissions (e.g. Microsoft

Internet Explorer version 4.01 or greater

or Netscape Communicator version 4.07

or greater, both are currently

downloadable for no cost from the

manufacturers; Microsoft: at http://

www.microsoft.com and Netscape:

http://www.netscape.com), word

processing or text editing software for

preparation of documents in a standard

format, e.g. RTF, ASCII, HTML, Adobe

Acrobat reader (downloadable for no

cost from the manufacturer at http://

www.adobe.com/), and electronic mail

service. CDC welcomes comments about

the use of these technologies.

Existing E-Grants Systems

CDC knows of existing software

available to universities which supports

grants applications and management

activities, but is unaware of which are

the leading systems currently in use in

universities. Similarly, CDC knows of

other Federal agencies beginning to use

‘‘E-Grants’’ systems. CDC is interested in

knowing whether CDC grantees and

potential applicants are using these

systems or have considered the use of

these systems and what the experience

has been. If you, or your organization

have similar plans or experiences with

E-Commerce, E-Grants, or knowledge of

the use of commercial off-the-shelf

packages, that information would be

particularly meaningful to CDC.

Electronic Forms

CDC frequently makes electronic

copies of application materials,

including standard Federal forms,

available on the web for downloading

and/or printing. CDC is interested in

whether customers find this useful or

would prefer paper forms.

E-Signature

CDC requires the use of several

assurance and certification documents

in the process to make awards. The

agency is interested in whether grantees

or potential applicants may already be

using electronic signatures in lieu of

paper-based signatures for legallybinding government grant and/or

contract activities and, if so, which

technologies.

Virtual Reviews

CDC conducts expert review of both

scientific and programmatic applicants

for funding. Reviewers are often

required to participate in review

activities on-site at the agency or within

a short distance from the agency’s

facility. CDC is interested in knowing

whether the use of distance-based

reviews conducted electronically would

impact the quality of peer reviews and

pose a barrier to or enhance the

recruitment of external reviewers for

panels, and to what extent you’ve

already participated in distance-based

reviews.

Please send comments or questions

within 60 days of this published notice:

via e-mail to: CDCegrants@cdc.gov

via facsimile to: E-Grants (attention Jim

Seligman) at 404–639–7113

via letter to: Centers for Disease Control

and Prevention, Attention: Jim

Seligman E-Grants, 1600 Clifton Rd,

MS D15, Atlanta, GA 30333.

Please provide a point of contact with

your comments for any follow-up

questions CDC may have and indicate

the type of organization you represent,

e.g. university, state government, local

government, community based

organization, etc. CDC intends to use the

information and comments received in

response to this notice in its planning

process for an electronic grants system.

No summary of comments or published

response to comments is planned. All

comments received by the agency will

be considered to be in the public

domain.

Dated: September 21, 2000.

Joseph R. Carter,

Associate Director for Management and

Operations, Centers for Disease Control and

Prevention.

[FR Doc. 00–24754 Filed 9–27–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Dental Products Panel of the Medical

Devices Advisory Committee; Notice of

Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Dental Products

Panel of the Medical Devices Advisory

Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on

FDA’s regulatory issues.

Date and Time: The meeting will be

held on October 6, 2000, 8:30 a.m. to

5:30 p.m.

Location: Corporate Bldg., conference

room 020B, 9200 Corporate Blvd.,

Rockville, MD.

Contact Person: Pamela D. Scott,

Center for Devices and Radiological

Health (HFZ–480), Food and Drug

Administration, 9200 Corporate Blvd.,

Rockville, MD 20850, 301–827–5283, or

FDA Advisory Committee Information

Line, 1–800–741–8138 (301–443–0572

in the Washington, DC area), code

12518. Please call the Information Line

for up-to-date information on this

meeting.

Agenda: The committee will discuss,

make recommendations, and vote on a

premarket approval application for a

glenoid fossa prosthesis that is used

alone to reconstruct the

temporomandibular joint (TMJ). The

committee will also discuss and make

recommendations on the labeling for a

total TMJ prosthesis.

Procedure: On October 6, 2000, from

9 a.m. to 5:30 p.m., the meeting is open

to the public. Interested persons may

present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by September 28, 2000. Oral

presentations from the public will be

scheduled between approximately 9:15

a.m. and 9:45 a.m. on October 6, 2000.

Near the end of committee

deliberations, a 30-minute open public

session will be conducted for interested

persons to address issues specific to the

submission before the committee. Time

allotted for each presentation may be

limited. Those desiring to make formal

oral presentations should notify the

contact person before September 28,

2000, and submit a brief statement of

the general nature of the evidence or

arguments they wish to present, the

names and addresses of proposed

participants, and an indication of the

approximate time requested to make

their presentation.

Closed Committee Deliberations: On

October 6, 2000, from 8:30 a.m. to 9

a.m., the meeting will be closed to

permit discussion and review of trade

secret and/or confidential commercial

information (5 U.S.C. 552b(c)(4))

regarding dental device issues.

Federal Register / Vol. 65, No. 189 / Thursday, September 28, 2000 / Notices 58279

FDA regrets that it was unable to

publish this notice 15 days prior to the

October 6, 2000, Dental Products Panel

of the Medical Devices Advisory

Committee meeting. Because the agency

believes there is some urgency to bring

this issue to public discussion and

qualified members of the Dental

Products Panel of the Medical Devices

Advisory Committee were available at

this time, the Commissioner of Food

and Drugs concluded that it was in the

public interest to hold this meeting even

if there was not sufficient time for the

customary 15-day public notice.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: September 20, 2000.

Bernard A. Schwetz,

Acting Deputy Commissioner.

[FR Doc. 00–24999 Filed 9–26–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–10000]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration, DHHS. In compliance

with the requirement of section

3506(c)(2)(A) of the Paperwork

Reduction Act of 1995, the Health Care

Financing Administration (HCFA),

Department of Health and Human

Services, is publishing the following

summary of proposed collections for

public comment. Interested persons are

invited to send comments regarding this

burden estimate or any other aspect of

this collection of information, including

any of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Request:

Extension of a currently approved

collection; Title of Information

Collection: Medicare Consumer

Assessment Survey of Health Plan

Survey (CAHPS)—Fee for Service;

HCFA Form Number: HCFA–10000

(OMB approval #: 0938–0796); Use:

Under the Balanced Budget Act of 1997,

HCFA is required to provide general and

plan comparative information to

beneficiaries that will help them make

more informed health plan choices. A

CAHPS fee for service survey is needed

to provide information comparable to

those data collected from the CAHPS

managed care survey; Frequency:

Annually; Affected Public: Individuals

or households; Number of Respondents:

168,000; Total Annual Responses:

134,400; Total Annual Burden Hours:

44,800.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, access HCFA’s Web

Site address at http://www.hcfa.gov/

regs/prdact95.htm, or E-mail your

request, including your address, phone

number, OMB number, and HCFA

document identifier, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Security and Standards Group, Division

of HCFA Enterprise Standards,

Attention: Julie Brown, Room N2–14–

26, 7500 Security Boulevard, Baltimore,

Maryland 21244–1850.

Dated: September 20, 2000.

John P. Burke III,

Reports Clearance Officer, Security and

Standards Group, Division of HCFA

Enterprise Standards.

[FR Doc. 00–24918 Filed 9–27–00; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration Establishment of the

Advisory Committee on Organ

Transportation and Solicitation of

Nominations for Membership

AGENCY: Health Resources and Services

Administration (HRSA), HHS.

ACTION: Notice of establishment of the

Advisory Committee on Organ

Transplantation and Solicitation of

Nominations for Membership.

SUMMARY: Pursuant to 42 CFR 121.12

and Public Law 92–463, the Federal

Advisory Committee Act, as amended (5

U.S.C. Appendix 2), the Administrator,

HRSA, announces the establishment of

the Advisory Committee on Organ

Transplantation by the Secretary, HHS.

The Committee will advise the Secretary

through the Administrator, HRSA, on all

aspects of organ procurement,

allocation, and transplantation, and on

such other matters that the Secretary

determines.

Duration of this Committee is for two

years unless renewed by the Secretary,

HHS.

This notice also requests nominations

for membership on the Committee.

DATES: Nominations for members must

be received no later than 5 p.m. on

October 30, 2000.

ADDRESSES: You may mail or deliver

nominations to the following address:

Lynn Rothberg Wegman, M.P.A.,

Director, Division of Transplantation,

5600 Fishers Lane, Room 7C–22,

Rockville, MD 20857.

A request for a copy of the charter for

the Advisory Committee should be

submitted to: Miguel Kamat, Division of

Transplantation, 5600 Fishers Lane,

Room 7C–22, Rockville, MD 20857 or

may be viewed on the Division’s

website at www.hrsa.gov/osp/dot

FOR FURTHER INFORMATION CONTACT:

Lynn Rothberg Wegman, (301) 443–

7577.

SUPPLEMENTARY INFORMATION:

I. Background and Authority

As provided by 42 CFR 121.12 (64 FR

56661), the Secretary has established the

Advisory Committee on Organ

Transplantation. The Committee is

governed by the Federal Advisory

Committee Act (5 U.S.C. Appendix 2),

which sets forth standards for the

formation and use of advisory

committees.

The Advisory Committee shall advise

the Secretary, acting through the

Administrator, HRSA, on all aspects of

organ procurement, allocation, and

transplantation, and on such other

matters that the Secretary determines,

including:

(1) Proposed enforceable policies of

the Organ Procurement and

Transplantation Network (OPTN)

submitted for Secretarial approval.

(2) Organ allocation policies of the

OPTN.

(3) Other significant OPTN policies,

existing or proposed.

(4) The OPTN’s system of collecting,

disseminating and ensuring the validity,

accuracy, timeliness and usefulness of

data.

(5) The current state of knowledge

regarding transplantation.

(6) Additional scientific, medical,

public health, ethical, legal, coverage

and financing issues and socioeconomic

issues, including national and

international policies and